Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy

Bibliographic Details
Main Authors: I. J. Pouliquen, P. Howarth, D. Austin, G. Gunn, E. Meyer, R. G. Price, E. Bradford
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13223-017-0217-6
_version_ 1811328530977390592
author I. J. Pouliquen
P. Howarth
D. Austin
G. Gunn
E. Meyer
R. G. Price
E. Bradford
author_facet I. J. Pouliquen
P. Howarth
D. Austin
G. Gunn
E. Meyer
R. G. Price
E. Bradford
author_sort I. J. Pouliquen
collection DOAJ
first_indexed 2024-04-13T15:26:48Z
format Article
id doaj.art-714380dda22d4b5982409483e23dbaa3
institution Directory Open Access Journal
issn 1710-1492
language English
last_indexed 2024-04-13T15:26:48Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj.art-714380dda22d4b5982409483e23dbaa32022-12-22T02:41:29ZengBMCAllergy, Asthma & Clinical Immunology1710-14922017-11-011311210.1186/s13223-017-0217-6Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapyI. J. Pouliquen0P. Howarth1D. Austin2G. Gunn3E. Meyer4R. G. Price5E. Bradford6Clinical Pharmacology Modelling & Simulation, GlaxoSmithKlineRespiratory Franchise, GlaxoSmithKlineClinical Pharmacology Modelling & Simulation, GlaxoSmithKlineImmunogenicity and Clinical Immunology, GlaxoSmithKlineImmunogenicity and Clinical Immunology, GlaxoSmithKlineClinical Statistics, GlaxoSmithKlineRespiratory Therapeutic Area, GlaxoSmithKlinehttp://link.springer.com/article/10.1186/s13223-017-0217-6Case reportSevere eosinophilic asthmaMepolizumabOCSIL-5
spellingShingle I. J. Pouliquen
P. Howarth
D. Austin
G. Gunn
E. Meyer
R. G. Price
E. Bradford
Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
Allergy, Asthma & Clinical Immunology
Case report
Severe eosinophilic asthma
Mepolizumab
OCS
IL-5
title Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
title_full Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
title_fullStr Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
title_full_unstemmed Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
title_short Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
title_sort response to case report airway autoimmune responses in severe eosinophilic asthma following low dose mepolizumab therapy
topic Case report
Severe eosinophilic asthma
Mepolizumab
OCS
IL-5
url http://link.springer.com/article/10.1186/s13223-017-0217-6
work_keys_str_mv AT ijpouliquen responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT phowarth responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT daustin responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT ggunn responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT emeyer responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT rgprice responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy
AT ebradford responsetocasereportairwayautoimmuneresponsesinsevereeosinophilicasthmafollowinglowdosemepolizumabtherapy